Remove Clinical Trials Remove Patients Remove Sleep Remove Treatment
article thumbnail

First Ever Clinical Trial for Cannabis Migraine Treatment is Underway

Veriheal

However, there has not been a clinical trial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinical trial for cannabis as a migraine treatment is underway. The First Clinical Trial for Migraines and Cannabis.

article thumbnail

Epilepsy and MMJ: Exploring the Promising Treatment Benefits

MMJ Recs

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ).

Epilepsy 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Cannabis Law Report

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.

article thumbnail

CBN: The Sleep-Inducing Cannabinoid

Kind Meds (Cannabis Education Blog)

CBN is a popular cannabinoid, but what should we know about CBN and sleep? Currently, CBN is mostly used by the general population as a sleep-inducing aid. However, it may do more than just induce sleep—many fans of CBN report that it makes for longer-lasting, more satisfying sleep. CBN and Sleep: FAQs.

Sleep 94
article thumbnail

Cannabinoids for Tinnitus?

Project CBD

For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc.

article thumbnail

1 in 5 Parkinson’s Patients Use Cannabis

CannaMD

As the study authors stated: The wider availability [of marijuana] means Parkinson’s patients have more of an opportunity now to experiment with it as a potential means of controlling their symptoms. However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms.

Patients 105
article thumbnail

Why more Parkinson’s patients don’t use cannabis

The Cannigma

Published in Nature Partner Journals and sponsored by the Parkinson’s Foundation, the study found that nearly 25% of Parkinson’s patients had used cannabis in the past six months, but that one in four of that group did not know what type or form of cannabis they used, and nearly half did not know their dosage. Of the 43.9% Altogether, 24.5%

Patients 138